Therefore understanding how TF signaling occurs in PCa progression can lead to the development of strategies for targeting these changes through targeted epigenetic therapies28–30, or the downstream gene networks may be uniquely drug-sensitive31,32. The gene discussed is TF; the disease is posterior cortical atrophy.